Bull takes a dose of Spectrum Pharma
Mike Yamamoto | email@example.com
Our Heat Seeker detected the purchase of 3,500 November 16 calls for $0.45 at the same second in the final hour of trading yesterday. This is clearly new buying, as open interest in the strike was only 749 contracts at the beginning of the day.
SPPI fell 3.24 percent to end the session at $12.23. The hematology and oncology drug developer gapped lower on Aug. 8 after reporting quarterly results even though it beat earnings and revenue forecasts.
If yesterday's long calls are held until they expire in mid-November, the stock would need to be above $16.45 at that time for the options to be profitable--a level seen just three weeks ago. Premiums on those contracts could also increase well before expiration if the shares rise by lesser margins, providing an opportunity to sell the calls with gains sooner. (See our Education section)
The trading pushed overall option volume in the name to nearly double its daily average. Calls outnumbered puts by 3 to 1, a reflection of the bullish sentiment.
(A version of this post appeared on InsideOptions Pro yesterday.)